Sutherland Everett Rand reported KRYS

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001852880-26-000002

Machine-readable

Structured copy

Timestamps

Event (reported)

Sep 14, 2026

Published

Sep 16, 2026

Ingested by INSIDER

Nov 5, 02:16 UTC

Last re-read

Nov 5, 02:16 UTC

Extracted facts

Filer

Sutherland Everett Rand

Role

Director

Transaction

Grant or awardAs filed: “A”

Asset

Krystal Biotech, Inc. — Restricted Stock Units

Ticker

KRYS

Shares

471

Price per share

$0

Execution date (reported)

Sep 14, 2026

Owned after transaction

471 shares

Days from execution to publication

2

What this establishes

Sutherland Everett Rand filed this Form 4 reporting a grant or award of KRYS on Sep 14, 2026. It became public on Sep 16, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Sutherland Everett Randcik:0001852880

Issuer

Krystal Biotech, Inc.cik:0001711279

Revision history · 0

No field has changed since this record was first ingested.